Volume 17, Issue 1

Efficacy and safety of the pharmacotherapy used in the management of hyperkalemia: a systematic review

Fabiana R. Varallo, Victória Trombotto, Rosa C. Lucchetta, Patricia de C. Mastroianni

pp. 1–13 · DOI: 10.18549/PharmPract.2019.1.1361 · Published 4 March 2019

Background: Although the management of hyperkalemia follows expert guidelines, treatment approaches are based on traditionally accepted practice standards. New drugs have been assessed such as sodium zirconium cyclosilic…

Evaluation of aldosterone antagonist utilization in heart failure with reduced and preserved ejection fraction at an academic medical center

Daniel Bradley, Jean Nappi

pp. 1–6 · DOI: 10.18549/PharmPract.2019.1.1376 · Published 10 March 2019

Background: Aldosterone antagonists (AA) have historically been underutilized despite evidence that they reduce morbidity, mortality, and readmission rates to the hospital when used appropriately. Objective: We sought to…

Effect of the pharmacist-managed cardiovascular risk reduction services on diabetic retinopathy outcome measures

Zachary A. Weber, Palakpreet Kaur, Amrita Hundal, Somnooma H. Ibriga, Ashay D. Bhatwadekar

pp. 1–6 · DOI: 10.18549/PharmPract.2019.1.1319 · Published Jan-Mar 2019

Background: Diabetic retinopathy (DR) is a progressive, sight-threatening long-term complication of diabetes. Diabetes disease management reduces the risk of developing or progression to a severe form of DR. However, the…

Evaluation of renal drug dosing adjustment in chronic kidney disease patients at two university hospitals in Lebanon

Rayane Saad, Souheil Hallit, Bahia Chahine

pp. 1–6 · DOI: 10.18549/PharmPract.2019.1.1304 · Published 27 February 2019

Background: Inappropriate medication dosing in patients with chronic kidney disease can cause toxicity or ineffective therapy. Patients are at a high risk of developing related adverse events caused by the altered effect…

Clinical pharmacist implementation of a medication assessment tool for long-term management of atrial fibrillation in older persons

Marise Gauci, Francesca Wirth, Lilian M. Azzopardi, Anthony Serracino-Inglott

pp. 1–7 · DOI: 10.18549/PharmPract.2019.1.1349 · Published Jan-Mar 2019

Background: Optimisation of drug therapy is important in the older population and may be facilitated by medication assessment tools (MATs). Objective: The purpose of the study was to evaluate whether appropriateness of d…

The impact of turmeric or its curcumin extract on nonalcoholic fatty liver disease: a systematic review of clinical trials

C. Michael White, Ji-Young Lee

pp. 1–5 · DOI: 10.18549/PharmPract.2019.1.1350 · Published 4 March 2019

Background: Turmeric and its curcumin extract have been evaluated in patients with nonalcoholic fatty liver disease (NAFLD), a common ailment that can lead to irreparable liver damage. Objective: To identify the evidence…

Communication skills in Brazilian pharmaceutical education: a documentary analysis

Dyego Carlos Souza Anacleto de Araújo, Janiely Sany Santos, Izadora Menezes da Cunha Barros, Afonso Miguel Cavaco, Alessandra Rezende Mesquita, Divaldo Pereira de Lyra Jr.

pp. 1–6 · DOI: 10.18549/PharmPract.2019.1.1395 · Published Jan-Mar 2019

Objective: To characterize the inclusion of the teaching of communication skills in the curriculum of Pharmacy Schools of Federal Institutions of Higher Education. Methods: An exploratory study of documental analysis of …

Effect of a smoking cessation educational intervention on knowledge and confidence of pharmacy students versus community leaders

Justin Joseph Sherman, Brett Lindsay Smith

pp. 1–7 · DOI: 10.18549/PharmPract.2019.1.1302 · Published Jan-Mar 2019

Background: Training programs of various intensities and durations have been implemented to assist healthcare providers and students in leading smokers in a quit attempt. While some training programs have been developed …

Evaluation of discharge prescriptions for secondary prevention in patients with acute coronary syndromes in Iraq

Ola A. Nassr, Paul Forsyth, Chris F. Johnson

pp. 1–7 · DOI: 10.18549/PharmPract.2019.1.1372 · Published 11 March 2019

Background: Optimal prescribing of secondary prevention medications after acute coronary syndrome (ACS) events has been shown to reduce morbidity and mortality. However, it is unknown whether these medications are optima…

A qualitative assessment of the pediatric content in pharmacy curricula adopted by pharmacy schools in Jordan

Tareq L. Mukattash, Anan S. Jarab, Rana K. Abu-Farha, Mohammad B. Nusair

pp. 1355 · DOI: 10.18549/PharmPract.2019.1.1355 · Published 14 March 2019

Objective: The present study aimed to explore faculty (i.e., professors of various ranks) opinions and views regarding the pediatric content in courses taught to pharmacy students in Jordan. Methods: Purposeful sampling …

Community pharmacy ethical practice in Jordan: assessing attitude, needs and barriers

Rajaa A. AL-QUDAH, Omar TUZA, Haneen TAWFIEK, Betty CHAAR, Iman A. BASHETI

pp. 1386 · DOI: 10.18549/PharmPract.2019.1.1386 · Published 17 March 2019

Background: Having a local code of ethics, based on moral obligations and virtues, known to all practicing pharmacists is important in order to guide them in relationships with patients, health professionals, and society…

Perceptions in the community about the use of antibiotics without a prescription: Exploring ideas behind this practice

Johanna Aponte-González, Angélica González-Acuña, José Lopez, Paul Brown, Javier Eslava-Schmalbach

pp. 1394 · DOI: 10.18549/PharmPract.2019.1.1394 · Published 10 March 2019

Objective: The use of antibiotics without prescription is common in Colombia as well as in other developing countries. The objective of this study is to explore the attitudes and motivations associated with the use of an…

Prevalence of pain and treatment outcomes among cancer patients in a Malaysian palliative care unit

Melissa Mejin, Thamron Keowmani, Syuhaidah Abdul Rahman, Jerry Ee Siung Liew, Jacqueline Mui Lan Lai, Morna Wui Lang Chua, Ilmiyah Che Wan

pp. 1397 · DOI: 10.18549/PharmPract.2019.1.1397 · Published 18 March 2019

Background: Pain remains one of the most common and debilitating symptoms of advanced cancer. To date, there is a lack of studies on pain and its treatment among Malaysian palliative care patients. Objective: This study …

Anaemia in heart failure patients: the prevalence of haematinic deficiencies and the role of ACE inhibitors and aspirin doses as risk factors

Kyrillos Guirguis

pp. 1406 · DOI: 10.18549/PharmPract.2019.1.1406 · Published 13 March 2019

Background: Patients with heart failure often have comorbidities that alter the progression of heart failure and impact on prognosis. One such comorbidity is anaemia, and clinicians have started to appreciate the full gr…

Expanding the role of Australian pharmacists in community pharmacies in chronic pain management - a narrative review

John Mishriky, Ieva Stupans, Vincent Chan

pp. 1–6 · DOI: 10.18549/PharmPract.2019.1.1410 · Published Jan-Mar 2019

Chronic pain is a condition where patients continuously experience pain symptoms for at least 3 to 6 months. It is one of the leading causes of disabilities across the globe. Failure to adequately manage chronic pain oft…

Peer review and publication delay

Fernando Fernández-Llimós

pp. 1–3 · DOI: 10.18549/PharmPract.2019.1.1502 · Published 21 May 2019

Selecting peer reviewers is a crucial stage of the editorial process that ensures the quality of scholarly publications. An alternative to selecting peer reviewers from data bases created with expressions of interest of …

Practice Forum: A new section led by the Center for Pharmacy Practice Innovation at Virginia Commonwealth University School of Pharmacy

Teresa M. Salgado, Dave L. Dixon

pp. 1495 · DOI: 10.18549/PharmPract.2019.1.1495 · Published 18 March 2019